123 results on '"Iwakuma, Nobutaka"'
Search Results
2. The effective duration of systemic therapy and the neutrophil-to-lymphocyte ratio predict the surgical advantage of primary tumor resection in patients with de novo stage IV breast cancer: a retrospective study
3. Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer
4. Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial)
5. Clinical outcomes of patients after nipple-sparing mastectomy and reconstruction based on the expander/implant technique
6. Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer
7. Nanotechnology
8. Multi-tracer sentinel node biopsy for patients with breast cancer after neoadjuvant chemotherapy
9. Nanotechnology
10. Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial)
11. Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancer
12. Nanotechnology
13. Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur–gimeracil–oteracil potassium in metastatic and recurrent breast cancer
14. Nanoparticle delivery for metastatic breast cancer
15. Primary breast peripheral T-cell lymphoma not otherwise specified: report of a case
16. Usefulness of endoscopic breast-conserving surgery for breast cancer
17. Nanotechnology
18. Paclitaxel as a first-line chemotherapy for Japanese women with advanced or recurrent breast cancer: a multi-institutional practice-based study by the Kyushu Breast Cancer Study Group (KBC-SG)
19. Multimodal Nanoparticulate Bioimaging Contrast Agents
20. What Is Cancer Nanotechnology?
21. Clinical outcomes of patients after nipple-sparing mastectomy and reconstruction based on the expander/implant technique
22. Early phase II study of mixed 19‐peptide vaccine monotherapy for refractory triple‐negative breast cancer
23. Abstract OT2-02-07: Fulvestrant with additional palbociclib in advanced or metastatic hormone receptor-positive HER2-negative breast cancer after progression to fulvestrant monotherapy: JBCRG- M07 (FUTURE trial)
24. Methotrexate (MTX)-associated malignant lymphoma of the bilateral breast: imaging features in comparison to other nipple-areolar tumors
25. A Case of Paget's Disease of the Male Breast
26. Association of PD-L1/CD8+TIL and expression of PD-L1, PTEN as predictive biomarkers for long-term follow-up in early breast cancer.
27. Feasibility study of multiple HLA-class IA restricted peptide vaccines (KRM-19) for metastatic triple negative breast cancer (TNBC).
28. IgG response against prostate-related antigen as potential biomarker for personalized peptide vaccination in metastatic recurrent breast cancer.
29. Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer
30. OR128 CTL AND IGG RESPONSE TO TUMOR-ASSOCIATED ANTIGENS AS PREDICTIVE FACTORS OF THERAPEUTIC PEPTIDE VACCINATION FOR PATIENTS WITH METASTATIC RECURRENT BREAST CANCER
31. HER2-targeted Therapeutic Strategies for HER2-positive Metastatic Breast Cancers
32. Nanotechnology
33. Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancer
34. Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients
35. Safety and immunologic efficacy of personalized multiple HLA class I-restricted peptide vaccines for breast cancer patients in the adjuvant setting.
36. Primary breast peripheral T-cell lymphoma not otherwise specified: report of a case
37. Effect of Preoperative Administration of Methylpredonisolone and Ulinastatin on Tumor Cell Metastasis after Surgical Stress
38. Usefulness of endoscopic breast-conserving surgery for breast cancer
39. Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy
40. Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur–gimeracil–oteracil potassium in metastatic and recurrent breast cancer
41. FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis
42. The Effect of Starvation on Blood Stream Cancer Cell Metastasis to the Liver in Rat after Laparotomy
43. Active targeting nanoparticle for breast cancer diagnosis and treatment.
44. Nanoparticle delivery for metastatic breast cancer
45. Gadolinium‐Doped Silica Nanoparticles Encapsulating Indocyanine Green for Near Infrared and Magnetic Resonance Imaging
46. Phase II study of personalized peptide vaccine for refractory breast cancer patients.
47. Giant Malignant Phyllodes Tumor: A Case Report
48. Polyhydroxy Fullerenes for Non-Invasive Cancer Imaging and Therapy
49. In vivo photoacoustic imaging of tumor using gold nanoparticles as contrast agent
50. Near-infrared absorbing and luminescent gold speckled silica nanoparticles for photothermal therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.